PS Ratio
9.54
-0.35-3.54%
Wed, 27 Nov 2024 21:17:23 GMT
Summary:
Cartesian Therapeutics price to sales ratio is currently 9.54, with a fall of -0.35 (-3.54%) during the most recent trading day. Over the past year, it has increased by +4.03 (+73.14%). RNAC PS ratio is now -99.20% below its all-time high of 1190.60.RNAC PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC PS Ratio Performance
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | -3.5% | -3.5% | -3.5% | -11.4% |
| 1 m1 month | -7.0% | -12.5% | -7.0% | - |
| 3 m3 months | +70.0% | +26.8% | +50.7% | - |
| 6 m6 months | -43.5% | -26.7% | +4.6% | - |
| ytdytd | +122.4% | -12.9% | +310.0% | - |
| 1 y1 year | +73.1% | -48.9% | +140.4% | +38.8% |
| 5 y5 years | - | -62.3% | +497.0% | - |
RNAC PS Ratio High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 11.42 | -16.5% | 8.81 | +8.3% |
| 3 m | 3 months | 12.34 | -22.7% | 5.39 | +77.0% |
| 6 m | 6 months | 25.80 | -63.0% | 5.09 | +87.4% |
| 1 y | 1 year | 25.80 | -63.0% | 2.83 | +237.1% |
| 3 y | 3 years | 25.80 | -63.0% | 0.95 | +904.2% |
| 5 y | 5 years | 58.44 | -83.7% | 0.95 | +904.2% |
| alltime | all time | 1190.60 | -99.2% | 0.95 | +904.2% |
Cartesian Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2024 | 9.54(+122.4%) |
| 2023 | 4.29(+175.0%) |
| 2022 | 1.56(-67.1%) |
| 2021 | 4.74(-76.0%) |
| Date | Value |
|---|---|
| 2020 | 19.73(-35.9%) |
| 2019 | 30.77(-53.5%) |
| 2018 | 66.20(-93.7%) |
| 2017 | 1058.91(+2606.8%) |
| 2016 | 39.12 |
FAQ
- What is Cartesian Therapeutics price to sales ratio?
- What is the all time high PS ratio for Cartesian Therapeutics?
- What is RNAC price to sales ratio year-to-date change?
- What is Cartesian Therapeutics PS ratio year-on-year change?
What is Cartesian Therapeutics price to sales ratio?
The current PS ratio of RNAC is 9.54
What is the all time high PS ratio for Cartesian Therapeutics?
Cartesian Therapeutics all-time high price to sales ratio is 1190.60
What is RNAC price to sales ratio year-to-date change?
Cartesian Therapeutics price to sales ratio has changed by +5.25 (+122.38%) since the beginning of the year
What is Cartesian Therapeutics PS ratio year-on-year change?
Over the past year, RNAC price to sales ratio has changed by +4.03 (+73.14%)